Navigation Links
Essential Pharmaceuticals LLC releases Cell-Ess serum replacement for use in cell culture instead of FBS

EWING, N.J., July 16, 2014 /PRNewswire/ -- Essential Pharmaceuticals LLC, Ewing NJ announces the release of Cell-Ess® serum replacement for cell culture.  Cell-Ess is a replacement for the Fetal Bovine Serum (FBS) that is commonly used in cell culture. The product is chemically defined, animal component free and delivers critical components that are needed for cell growth.  

Cell-Ess enables researchers to eliminate FBS use in both basic research and bio-production of proteins or cells used Cell-Ess provides a greater level of performance, convenience and control not always attainable when using FBS. Some inherent limitations when using FBS in cell culture are that it is an animal product, containing viral and bacterial contaminants harmful to humans, isn't consistent lot to lot, and requires special handling or processing before it can be used.

"By better duplicating biological processes, Cell-Ess will enable researchers to advance discovery by seeing more relevant results from the cell culture models they use today" says Allan Weber, CEO of Essential Pharmaceuticals.  "It also increases product safety by providing a high performance, animal component free, alternative to FBS when used in bio-production to synthesize proteins.

Cell culture enables scientists to conduct thousands of simultaneous experiments and understand cell behavior and metabolic processes without using humans or animals. FBS has been a critical component of the media that is used to culture cells. FBS contains hundreds of growth factors, hormones and plating factors that help cells grow. At one time it was most important to simply have billions of cells for experiments. Now it is becoming more apparent that factors in FBS signal cells to perform in ways that are not the same as when those cells are in a tissue or organ. These cell signaling factors obscure the ability of scientists to elucidate metabolic pathways that lead to a healthy or disease state.

"At Essential Pharmaceuticals we aim to provide solutions to manage organs, tissues and individual cells for research purposes" says Allan Weber, CEO.

Essential Pharmaceuticals, LLC was established in 2006 and is best known for its role supporting the organ transplant market by providing the organ preservation solution, Custodiol HTK®. Custodiol HTK is indicated for perfusion and flushing of donor kidneys, liver, pancreas and heart prior to removal from the donor or immediately after removal from the donor.  It is also the only organ preservation solution in the United States that is FDA approved for the perfusion and preservation of both abdominal and thoracic organs.

Cell-Ess is only the first of a series of planned "Ess" product releases this year. This launch will be followed by Cryo-Ess®, an animal component free and non-toxic, cell cryopreservation medium and

Clin-Ess®, a non-toxic, animal component free transportation medium for tissue.  Ess products are designed to help research scientists advance discovery in areas of drug development, cancer, autoimmune disease, metabolic disease, regenerative medicine, cell therapy and others.

For more information visit or contact our corporate office: 609 323-7838. Email:

Photo -

SOURCE Essential Pharmaceuticals, LLC
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Essential Medical Dismisses Patent Case against Masimo and Cercacor
2. Vertellus Specialties Selects HORN Essentials as Regional Distribution Partner in US West and Southwest for Personal and Consumer Care Products
3. New Online Store Offers Essential Surgical-Quality Tweezers, Holiday Gift Sets and more
4. PCMA Statement on Essential Health Benefits Proposed Rule
5. AVAC Report Finds That World is Already Falling Behind Pace to End AIDS Epidemic; Five Essential Actions Needed in 2013 to Avoid Historic Missed Opportunity
6. United Spinals UsersFirst Mobilizes Wheelchair Users to Demand Access to Essential Mobility Equipment
7. The Essential Guide to Prescription Drugs, 12 Top Meds for 2012 available!
8. Power Wheelchairs Essential to Reasonable Quality of Life for Many Medicare Beneficiaries
9. Physician-Patient Alliance for Health & Safety Announces Four Essentials for Safety for Patients Receiving Opioids
10. Protein Targeted For Cancer Drug Development Is Essential For Normal Heart Function
11. FDAnews Announces Leading the Climb: Seven Essentials of GMP Workshop
Post Your Comments:
(Date:6/24/2016)... , June 24, 2016 ... Market by Type (Standard Pen Needles, Safety Pen Needles), ... (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) ... MarketsandMarkets, This report studies the market for the forecast ... to reach USD 2.81 Billion by 2021 from USD ...
(Date:6/23/2016)... , June 23, 2016  MedSource announced today ... its e-clinical software solution of choice.  This latest ... possible value to their clients by offering a ... preferred relationship establishes nowEDC as the EDC platform ... MedSource,s full-service clients.  "nowEDC has long been a ...
(Date:6/23/2016)... , June 23, 2016  In a startling report released today, ... their residents by lacking a comprehensive, proven plan to eliminate prescription ... definitive ranking of how states are tackling the worst drug crisis ... four states – Kentucky , New ... Vermont . Of the 28 failing states, three – ...
Breaking Medicine Technology:
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... Austin residents ... the American College of Mohs Surgery and to Dr. Russell Peckham for medical and ... highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... As a ... Magna Cum Laude and his M.D from the David Geffen School of Medicine at ... returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... are unfamiliar with. The article goes on to state that individuals are now more ... these less common operations such as calf and cheek reduction. The Los Angeles area ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Sessions in Dallas that it will receive two significant new grants to support ... as PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists ...
(Date:6/24/2016)... ... ... BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a ... an hour by 2020 and then adjusting it yearly to increase at the same rate ... assure the wage floor does not erode again, and make future increases more predictable. , ...
Breaking Medicine News(10 mins):